Cover Image
市場調查報告書

小腸結腸炎 :全球臨床實驗趨勢

Enterocolitis Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 229140
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
小腸結腸炎 :全球臨床實驗趨勢 Enterocolitis Global Clinical Trials Review, H2, 2017
出版日期: 2017年08月11日 內容資訊: 英文 83 Pages
簡介

本報告提供小腸結腸炎相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,G7及E7各國的臨床實驗狀況,各地區、Phase、階段別進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 小腸結腸炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:小腸結腸炎臨床實驗數量上消化管疾病臨床實驗數量比率

Phase別臨床實驗數量:G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:小腸結腸炎臨床實驗數量上消化管疾病臨床實驗數量比率

Phase別臨床實驗數量:E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗的主要參與企業 - 小腸結腸炎治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Sigma-Tau S.p.A.
    • Sanofi
    • Pharmbio Korea Co.,Ltd.
    • Nestle S.A.
    • CD Pharma India Private Ltd.
  • 有代表性的研究機關/醫院臨床實驗概要
    • Dr. Sami Ulus Children's Hospital
    • Great Ormond Street Hospital for Children NHS Trust
    • Ain Shams University
    • Coordinacion de Investigacion en Salud
    • Duke University
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • John D. Dingell VA Medical Center
    • Shaare Zedek Medical Center
    • Wake Forest University
    • Zekai Tahir Burak Maternity and Teaching Hospital

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4440CTIDB

GlobalData's clinical trial report, "Enterocolitis Global Clinical Trials Review, H2, 2017" provides an overview of Enterocolitis clinical trials scenario. This report provides top line data relating to the clinical trials on Enterocolitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Enterocolitis to Gastrointestinal Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Enterocolitis to Gastrointestinal Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Enterocolitis Therapeutics Clinical Trials 30
  • Prominent Drugs 31
  • Clinical Trial Profile Snapshots 32

Appendix 81

  • Abbreviations 81
  • Definitions 81
  • Research Methodology 82
  • Secondary Research 82
  • About GlobalData 83
  • Contact Us 83
  • Source 83

List of Tables

List of Tables

  • Enterocolitis Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Enterocolitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Enterocolitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Enterocolitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Enterocolitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Enterocolitis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Enterocolitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Enterocolitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
  • Proportion of Enterocolitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 15
  • Enterocolitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Enterocolitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Enterocolitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 18
  • Enterocolitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Enterocolitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Enterocolitis Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Enterocolitis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Enterocolitis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Enterocolitis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Enterocolitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Enterocolitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Enterocolitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Enterocolitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Enterocolitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures

List of Figures

  • Enterocolitis Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Enterocolitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Enterocolitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Enterocolitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Enterocolitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Enterocolitis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Enterocolitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Proportion of Enterocolitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 15
  • Enterocolitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Enterocolitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Enterocolitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 18
  • Enterocolitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Enterocolitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Enterocolitis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Enterocolitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Enterocolitis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Enterocolitis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Enterocolitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Enterocolitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Enterocolitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Enterocolitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Enterocolitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
  • GlobalData Methodology 82
Back to Top